You are viewing: Europe Negative Pressure Wound Therapy Market analysis

The Europe Negative Pressure Wound Therapy Market was valued at $658.97 Million in 2025 and projected to reach to $912.63 Million by 2030, representing a compound annual growth rate of 6.7%. Europe's Negative Pressure Wound Therapy market is poised for steady growth through 2030, driven by an aging population with increasing chronic wound prevalence and strong healthcare infrastructure supporting advanced treatment adoption.

Europe Negative Pressure Wound Therapy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Negative Pressure Wound Therapy Market Trends and Insights

  • Europe's advanced healthcare infrastructure, aging population, and high prevalence of chronic wounds drive demand for NPWT solutions across the region.
  • The market in Europe benefits from strong reimbursement policies, established clinical guidelines, and widespread adoption of advanced wound care technologies among hospitals and outpatient facilities. Growth in Europe's NPWT market is supported by increasing surgical procedures, rising incidence of diabetic foot ulcers, and venous leg ulcers across the continent.
  • Europe's regulatory environment, including CE marking requirements, ensures product quality and safety, fostering consumer confidence.
  • Between 2025 and 2030, Europe is anticipated to see accelerated adoption driven by healthcare system modernization, growing awareness among clinicians, and expanding access to NPWT in both urban and emerging healthcare markets. Europe's competitive landscape features both established multinational manufacturers and regional players offering innovative NPWT devices and consumables.
  • The region's emphasis on cost-effectiveness and clinical outcomes continues to shape product development and market strategies throughout the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 6.7% CAGR
  • Market Size, 2025 ~USD 658.97 Million
  • Forecast, 2030 ~USD 912.63 Million
  • Geography Europe

Europe Negative Pressure Wound Therapy Market Overview

Market Valuation & Growth :

Europe's Negative Pressure Wound Therapy market is valued at $658.97 million in 2025 and is projected to reach $912.63 million by 2030, growing at a CAGR of 6.7%, slightly below the global average of 6.9%.

Aging Population Driver :

Europe's rapidly aging demographic is a key growth catalyst, with increased prevalence of chronic wounds, diabetic ulcers, and post-surgical complications driving sustained demand for advanced NPWT solutions across the region.

Strong Healthcare Infrastructure :

Advanced healthcare systems, robust reimbursement policies, and high adoption rates of innovative wound care technologies position Europe as a mature and stable market for NPWT solutions.

Regional Market Leaders :

Germany ($536.3M) and Italy ($869.4M) are dominant markets, while the UK ($137.41M), Spain ($336.5M), and France ($62.12M) contribute significantly to Europe's overall NPWT market expansion.

Europe Negative Pressure Wound Therapy Market Dynamics

  • Favorable reimbursement frameworks across major European markets, including Germany, Italy, and Spain, facilitate patient access to NPWT solutions and encourage healthcare provider investment in these technologies. The market will benefit from ongoing clinical evidence supporting NPWT efficacy, rising awareness among healthcare professionals, and continuous product innovations.
  • However, growth may be tempered by market saturation in developed economies and pricing pressures.
  • Strategic focus on emerging European markets and integration of digital wound management solutions will be critical for sustained expansion through 2030..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Europe's NPWT market is projected to grow from $658.97M (2025) to $912.63M (2030) at a 6.7% CAGR, driven by aging demographics and chronic wound prevalence.
    • Europe's strong healthcare infrastructure and favorable reimbursement policies support widespread adoption of negative pressure wound therapy solutions.
    • Rising surgical procedures and increasing incidence of diabetic and venous ulcers across Europe are key growth catalysts through 2030.
    • Europe's stringent regulatory framework and emphasis on clinical outcomes foster innovation and competition among NPWT manufacturers in the region.

    Negative Pressure Wound Therapy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HOSPITALS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.9% from 2025 to 2030
    Largest Segment CONVENTIONAL NPWT DEVICES (Product Type)
    Market Size Base Year (Billions) ~USD 2.75 (2025)
    Revenue Forecast (Billions) ~USD 3.84 (2030)
    Segments Covered Product Type, Wound Type, End User

    Europe Negative Pressure Wound Therapy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product Type

    • Conventional Npwt Devices
    • Npwt Accessories & Consumables
    • Single-Use Npwt Devices

    By Wound Type

    • Burns And Surgical & Open Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Traumatic Wounds
    • Venous Leg Ulcers

    By End User

    • Home Care Settings
    • Hospitals
    • Other End Users

    EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    HOME CARE SETTINGS217.47228.44240.32253.22267.22282.69299.5317.795.7
    HOSPITALS304.66325.76348.97374.54402.74434.28469.16507.797.8
    OTHER END USERS64.6667.0569.6772.5375.6579.1282.9187.044.6
    TOTAL586.79621.25658.97700.29745.6796.08851.57912.636.7

    REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    HOME CARE SETTINGS34.2836.6439.2242.0545.1548.5952.3856.557.6
    HOSPITALS47.6551.8656.5561.7867.6274.2281.6189.919.7
    OTHER END USERS9.7310.2810.8711.5312.2413.0413.9114.876.5
    TOTAL91.6798.78106.64115.35125.01135.85147.91161.348.6

    Target Audience

    • Medical Device Manufacturers : NPWT device manufacturers need Europe-specific market data to optimize product positioning, identify distribution opportunities, and develop region-tailored commercialization strategies across diverse healthcare systems.
    • Healthcare Providers & Hospitals : Hospital networks and wound care centers require market intelligence to benchmark NPWT adoption rates, justify capital investments, and optimize procurement decisions within their European operations.
    • Private Equity & Investors : Investment firms evaluating European healthcare assets need detailed market forecasts, growth drivers, and competitive dynamics to assess investment opportunities and portfolio company valuations.
    • Pharmaceutical & Biotech Companies : Companies developing complementary wound care solutions need European market segmentation data to identify partnership opportunities, licensing potential, and market expansion pathways.
    • Healthcare Consultants & Analysts : Management consultants and research analysts require granular European market data to support client strategy development, competitive benchmarking, and market entry planning across the region.

    Key Companies in the Europe Negative Pressure Wound Therapy Market

    CompanyHQOwnershipStrongest segments
    NITTO DENKO CORPORATIONJapanPublic CompanyConventional NPWT (materials content),Single-use NPWT (materials content),NPWT Consumables (dressings, drapes, tapes),
    COLOPLAST A/SDenmarkPublic CompanyConventional NPWT systems,Single-use NPWT,Consumables,
    SOLVENTUMUnited StatesPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables (Dressings, Canisters, Interfaces),
    SMITH+NEPHEWUnited KingdomPublic CompanyConventional NPWT Systems,Single-use NPWT Systems,Consumables (Dressings & Canisters),
    CARDINAL HEALTHUnited StatesPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables,
    MöLNLYCKE ABSwedenPrivate CompanyConventional NPWT,Single-use NPWT,Consumables,
    CONVATEC GROUP PLCUnited KingdomPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables (Dressings, Canisters, Tubing),
    PAUL HARTMANN AGGermanyPublic CompanyConventional NPWT systems,Single-use NPWT,NPWT Consumables (dressings, canisters, tubing),
    AVERY DENNISON CORPORATIONUnited StatesPublic CompanyConventional NPWT (materials inputs),Single-use NPWT (materials inputs),Consumables (dressings, drapes, interface materials),
    BENQ MATERIALS CORPORATIONTaiwanPublic CompanyConventional NPWT systems,Single-use NPWT,NPWT consumables (dressings, drapes, canisters),
    DOUBLE MEDICAL TECHNOLOGY INC.ChinaPublic CompanyConventional NPWT Systems,Single-use NPWT,Consumables (Dressings & Canisters),

    NITTO DENKO CORPORATION

    Nitto Denko Corporation is a Japanese public company founded in 1918 with 26,477 employees. The company operates as a diversified manufacturer with operations across multiple industrial sectors.

    COLOPLAST A/S

    Coloplast A/S is a Danish public company established in 1954 with 17,083 employees. The company specializes in medical devices and healthcare solutions.

    SOLVENTUM

    Solventum is a United States public company established in 2023 with 20,584 employees. The company operates in the healthcare and industrial sectors.

    SMITH+NEPHEW

    Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. The company is a global medical technology provider specializing in orthopedics, wound care, and surgical products.

    CARDINAL HEALTH

    Cardinal Health is a United States public company founded in 1979 with 55,392 employees. The company is a major healthcare services and products distributor serving hospitals, pharmacies, and other healthcare providers.

    MöLNLYCKE AB

    Mölnlycke AB is a Swedish private company established in 1849 with 8,463 employees. The company specializes in healthcare and hygiene products.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees. The company develops and manufactures medical devices and products for ostomy care, continence care, and wound care.

    PAUL HARTMANN AG

    Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees. The company produces medical and hygiene products for healthcare and consumer markets.

    AVERY DENNISON CORPORATION

    Avery Dennison Corporation is a United States public company founded in 1935 with 35,000 employees. The company manufactures pressure-sensitive materials, labels, and packaging solutions for various industries.

    BENQ MATERIALS CORPORATION

    BenQ Materials Corporation is a Taiwan-based public company founded in 1998 with 1,317 employees. The company manufactures specialty materials and components.

    DOUBLE MEDICAL TECHNOLOGY INC.

    Double Medical Technology Inc. is a China-based public company founded in 2004 with 4,704 employees. The company manufactures medical devices and healthcare products.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 2154.1 Million · 6.2% wtd CAGR ·
    Asia Pacific
    ~USD 542.03 Million · 9.5% wtd CAGR ·
    Latin America
    ~USD 154.19 Million · 8.3% wtd CAGR ·
    Middle East & Africa
    ~USD 77.98 Million · 7.4% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    UKUSD 137.41 Million
    GermanyUSD 536.3 Million
    FranceUSD 62.12 Million
    ItalyUSD 869.4 Million
    SpainUSD 336.5 Million
    RussiaUSD 44.74 Million
    Rest Of EuropeUSD 106.35 Million

    Country market size visualization

    UK
    USD 137.41 Million
    Germany
    USD 536.3 Million
    France
    USD 62.12 Million
    Italy
    USD 869.4 Million
    Spain
    USD 336.5 Million
    Russia
    USD 44.74 Million
    Rest Of Europe
    USD 106.35 Million

    Reasons to Buy this Report

    • Country-Level Market Insights : Detailed market sizing and forecasts for major European markets including Germany, Italy, Spain, UK, and France, enabling precise regional investment and expansion strategies.
    • Reimbursement & Regulatory Analysis : Comprehensive understanding of European reimbursement policies, healthcare regulations, and pricing dynamics that directly impact market access and profitability across different countries.
    • Competitive Landscape Mapping : Identify key market players, competitive positioning, and market share distribution across Europe to inform strategic partnerships, acquisitions, and market entry decisions.
    • Growth Opportunity Identification : Pinpoint high-growth segments, emerging applications, and underserved markets within Europe to prioritize resource allocation and maximize return on investment.
    • Demographic & Clinical Trends : Access data on aging populations, chronic wound prevalence, and clinical adoption patterns specific to European markets to align product development and marketing strategies.

    Frequently asked questions

    What is the current market size of NPWT in Europe?

    Europe's Negative Pressure Wound Therapy market is valued at $658.97 million in 2025 and is expected to reach $912.63 million by 2030.

    What is the projected growth rate for Europe's NPWT market?

    Europe's NPWT market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2025 and 2030.

    What factors are driving growth in Europe's NPWT market?

    Key drivers include Europe's aging population, rising prevalence of chronic wounds, increasing surgical procedures, strong healthcare infrastructure, and favorable reimbursement policies.

    How does Europe's regulatory environment impact the NPWT market?

    Europe's CE marking requirements and stringent regulatory framework ensure product quality and safety, fostering consumer confidence and supporting market growth through 2030.

    Which wound types are most prevalent in Europe's NPWT market?

    Diabetic foot ulcers and venous leg ulcers are among the most prevalent wound types driving NPWT adoption across Europe's healthcare systems.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the negative pressure wound therapy market. Exhaustive secondary research was done to collect information on the negative pressure wound therapy industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the negative pressure wound therapy market.

    The four steps involved in estimating the market size are:

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global negative pressure wound therapy market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the negative pressure wound therapy market. The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    The following is a breakdown of the primary respondents:

    Negative Pressure Wound Therapy Market

    Note 1: Other designations include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global negative pressure wound therapy market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global negative pressure wound therapy market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of negative pressure wound therapy providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from negative pressure wound therapy (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global negative pressure wound therapy market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    The research methodology used to estimate the market size includes the following:

    Negative Pressure Wound Therapy Market

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Negative pressure wound therapy is a treatment that pulls fluid and bacteria out of a wound to help it heal better. Some healthcare providers call it vacuum-assisted therapy. It works by creating suction. A provider can use this treatment to heal soft tissue on many different parts of your body.

    Stakeholders

    • NPWT Device Manufacturers
    • Hospitals and ASCs
    • Research and Consulting Firms
    • Distributors of NPWT Devices
    • Contract Manufacturers of NPWT Devices
    • Venture Capitalists and Investors
    • Government Wound Care Organizations

    Report Objectives

    • To define, describe, segment, and forecast the global negative pressure wound therapy market by product type, wound type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall negative pressure wound therapy market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

     

    Get the Full Negative Pressure Wound Therapy Market Report

    Full forecast, segment splits, and company analysis for all Negative Pressure Wound Therapy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status